NCT03035227|TerminatedPhase 4ResultsDMCFDA Drug
Loading search results
Investigator left Institution.
ABLATE-CRT
Sponsor study identifier
interventional
2
1 country
1
Study Start
January 23, 2017
Actual (reported)Primary Completion
May 1, 2018
Actual (reported)Study Completion
May 1, 2018
Actual (reported)The purpose of this study is to test if catheter ablation is better than medication therapy at treating arrhythmias originating from the upper and/or lower chambers of the heart in order to allow the heart to beat properly.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 1, 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 23, 2017
Actual (reported)January 25, 2017
Actual (reported)January 27, 2017
Actual (reported)May 1, 2018
Actual (reported)May 1, 2018
Actual (reported)September 10, 2022
Actual (reported)Change in Ejection Fraction (EF)
Change in Ejection Fraction (EF)
90 Days
Bi-ventricular Pacing Improvement
data not analyzed
90 Days
Cardiovascular Mortality
data not analyzed
365Days
All-cause Mortality
365 Days
Hospital Admissions for Heart Failure Exacerbation
365 Days
New York Heart Association (NYHA) Class Change
30 Days
Change in 6 Minute Walk Test
30 Days
Change in Quality of Life - SF-36
30 Days
Catheter ablation procedure of atrial and/or ventricular arrhythmias.
Medical management using antiarrhythmic drugs per standard of care of treating physician.
Catheter ablation of atrial or ventricular arrhythmia. The technique and type of ablation will be at the discretion of the treating electrophysiologists.
Anti-Arrhythmic drugs that are deemed to be appropriate for the given participants's arrhythmia by the treating physician.
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
Dhanunjaya Lakkireddy, MD
Kansas City Heart Rhythm Institute
2 participants (actual enrollment reported by the registry).
First Submitted
January 25, 2017
First Posted
January 27, 2017
Study Start
January 23, 2017
Actual (reported)Efficacy and Safety of Sotalol in Children With Arrhythmia
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
May 1, 2018
Actual (reported)Study Completion
May 1, 2018
Actual (reported)Last Updated
September 10, 2022
Results First Posted
September 10, 2022
Record last verified: 2020-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: